Progress and challenges in childhood tuberculosis

The Lancet Infectious Diseases

Volumn 13, Issue 4, 2013, Pages 287-289

  Marais, Ben J ^a   Graham, Stephen M ^b   Maeurer, Markus ^c   Zumla, Alimuddin ^d,e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ETHAMBUTOL; ISONIAZID; PROTEINASE INHIBITOR; RIFAMPICIN;

DIAGNOSTIC ACCURACY; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION RISK; LETTER; MORBIDITY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROPHYLAXIS; RECOMMENDED DRUG DOSE; T LYMPHOCYTE; TUBERCULOSIS; TUBERCULOSIS CONTROL; VACCINATION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; BCG VACCINE; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNITY, INNATE; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; RISK FACTORS; TUBERCULOSIS; TUBERCULOSIS VACCINES; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84875616082     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70031-8     Document Type: Letter

References (19)

1. Global tuberculosis report 2012 2012, WHO, World Health Organization, Geneva, Switzerland.
2. Perez-Velez CM, Marais BJ Tuberculosis in children. N Engl J Med 2012, 367:348-361.
3. Chintu C, Mudenda V, Lucas S, et al. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet 2002, 360:985-990.
4. Bates M, O'Grady J, Maeurer M, et al. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study. Lancet Infect Dis 2013, 13:36-42.
5. Dodd LE, Wilkinson RJ Diagnosis of paediatric tuberculosis: the culture conundrum. Lancet Infect Dis 2013, 13:3-4.
6. Getahun H, Sculier D, Sismanidis C, Grzemska M, Raviglione M Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services. J Infect Dis 2012, 205:S216-S227.
7. Detjen AK, Macé C, Perrin C, Graham SM, Grzemska M Adoption of revised dosage recommendations for childhood tuberculosis in countries with different childhood tuberculosis burdens. Public Health Action 2012, 2:126-132.
8. Desk-guide for the diagnosis and management of TB in children 2010, International Union Against Tuberculosis and Lung Disease, International Union Against Tuberculosis and Lung Disease, Paris, France.
9. Hill PC, Rutherford ME, Audas R, van Crevel R, Graham SM Closing the policy-practice gap in the management of child contacts of tuberculosis in developing countries. PLoS Med 2011, 8:e10001105.
10. Marais B, Lönnroth K, Lawn SD, et al. Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis 2013, published online March 24. http://dx.doi.org/10.1016/S1473-3099(13)70015-X.
11. McShane H, Jacobs WR, Fine PE, et al. BCG myths, realities, and the need for alternative vaccine strategies. Tuberculosis 2012, 92:283-288.
12. Hesseling AC, Cotton M, Marais BJ, et al. BCG and HIV reconsidered: moving the research agenda forward. Vaccine 2007, 25:6565-6568.
13. Comas I, Chakravartti J, Small PM, et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet 2010, 42:498-503.
14. Wallis RS, Kim PS, Cole S, et al. Tuberculosis biomarkers discovery: developments, needs, and challenges. Lancet Infect Dis 2013, published online March 24. http://dx.doi.org/10.1016/S1473-3099(13)70034-3.
15. Benita-Bivas M, Gillard GO, Bar L, et al. Airway CD8+ T-cells induced by pulmonary DNA immunization mediate protective anti-viral immunity. Mucosal Immunol 2012, 6:156-166.
16. Ottenhoff THM The knowns and unknowns of the immunopathogenesis of tuberculosis. Int J Tuberc Lung Dis 2012, 16:1424-1432.
17. Donald PR, Marais BJ, Barry CE Age and the epidemiology and pathogenesis of tuberculosis. Lancet 2010, 375:1852-1854.
18. Mudenda V, Lucas S, Shibemba A, et al. Tuberculosis and tuberculosis/HIV/AIDS-associated mortality in Africa: the urgent need to expand and invest in routine and research autopsies. J Infect Dis 2012, 205(suppl 2):S340-S346.
19. Zumla A, Atun R, Maeurer M, et al. Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection. Trop Med Int Health 2011, 16:79-83.